- Home
- TAK vs SLF Comparison
TAK vs SLF Comparison
Compare TAK & SLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAK
- SLF
- Stock Information
- Founded
- TAK 1781
- SLF 1871
- Country
- TAK Japan
- SLF Canada
- Employees
- TAK N/A
- SLF N/A
- Industry
- TAK Biotechnology: Pharmaceutical Preparations
- SLF Advertising
- Sector
- TAK Health Care
- SLF Consumer Discretionary
- Exchange
- TAK Nasdaq
- SLF Nasdaq
- Market Cap
- TAK 45.8B
- SLF 37.5B
- IPO Year
- TAK N/A
- SLF N/A
- Fundamental
- Price
- TAK $14.68
- SLF $62.16
- Analyst Decision
- TAK
- SLF Buy
- Analyst Count
- TAK 0
- SLF 1
- Target Price
- TAK N/A
- SLF $88.00
- AVG Volume (30 Days)
- TAK 2.3M
- SLF 488.3K
- Earning Date
- TAK 07-30-2025
- SLF 08-07-2025
- Dividend Yield
- TAK 3.70%
- SLF 3.89%
- EPS Growth
- TAK N/A
- SLF 3.59
- EPS
- TAK 0.45
- SLF 3.81
- Revenue
- TAK $30,595,075,281.00
- SLF $23,434,793,186.00
- Revenue This Year
- TAK $1.01
- SLF N/A
- Revenue Next Year
- TAK $1.04
- SLF $4.18
- P/E Ratio
- TAK $65.09
- SLF $15.91
- Revenue Growth
- TAK 7.45
- SLF 7.25
- 52 Week Low
- TAK $12.80
- SLF $46.41
- 52 Week High
- TAK $15.53
- SLF $66.81
- Technical
- Relative Strength Index (RSI)
- TAK 41.31
- SLF 39.89
- Support Level
- TAK $14.93
- SLF $61.28
- Resistance Level
- TAK $15.14
- SLF $66.81
- Average True Range (ATR)
- TAK 0.15
- SLF 0.96
- MACD
- TAK -0.06
- SLF -0.52
- Stochastic Oscillator
- TAK 11.86
- SLF 17.09
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About SLF Sun Life Financial Inc.
Sun Life Financial is one of the Big Three Canadian life insurers. The Canadian business contributed around 38% of adjusted earnings. In that segment, the firm provides health, life insurance, and annuity products to individual and group customers. Its US business is mostly group health and contributed about 20% of the firm's adjusted earnings in 2024. Sun Life also offers life insurance and wealth products in several Asian markets with a strong presence in Hong Kong and the Philippines. The Asia segment contributed around 18% of adjusted 2024 earnings. Its asset management business had around CAD 1.1 trillion total assets under management or administration at the end of 2024 and represents around 34% of the firm's earnings.